Topics

Companies Related to "Akcea Pfizer Announce Licensing Agreement Investigative Antisense Therapy" [Most Relevant Company Matches] [Advanced Search Results] RSS

10:43 EST 6th December 2019 | BioPortfolio

Here are the most relevant search results for "Akcea Pfizer Announce Licensing Agreement Investigative Antisense Therapy" found in our extensive corporate database of over 50,000 company records.

Showing "Akcea Pfizer Announce Licensing Agreement Investigative Antisense Therapy" Companies 1–25 of 2,000+

Relevant

Pfizer Oncology

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers, including...


Pfizer Inc. and Astellas Pharma Inc.

In October 2009, Medivation, Inc., which is now part of Pfizer (NYSE:PFE), and Astellas (TSE: 4503) entered into a global agreement to jointly develop and commercialize enzalutamide. The companies jointly commercialize XTANDI in the United States and Astellas has responsibility for manufacturing and all additional regulatory filings globally, as well as commercializing XTANDI outside the United S...

The Pfizer Foundation

The Pfizer Foundation is a charitable organization established by Pfizer Inc. The Foundation is a separate and independent tax-exempt organization. The Foundation’s mission is to promote access to quality health care, to nurture innovation, and to support the community involvement of Pfizer people.


Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-based technologies, such as antisense. Very little was known about antisense when the Company was first established, but its founders envisioned an opportunity to revolutionize the pharmaceutical indus...

NCO Financial Investigative Services

NCO Financial Investigative Services (FIS) is a worldwide commercial due diligence firm, providing in-depth background investigations, public record research and detailed analysis to the global business community. NCO FIS is honored to be the 2009 Outsourcing Company of the Year- North America, according to ACQ Finance Magazine. NCO Financial Investigative Services is part of the NCO Group of comp...

Renata Limited

Historical High-Lights: Founded in 1972 as a subsidiary of Pfizer Inc. Ownership transferred from Pfizer Inc. to local institutions and the general public in 1993. Company name subsequently changed from Pfizer Laboratories (Bangladesh) Limited to Renata Limited.

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalmology to support patients who are at risk of blindness or suffering from vision impairment, and to serve the health care professionals who treat them. Its current product line includes the most presc...

California Innovations

California Innovations is the worldwide market leader in insulated products. In 2004, the company acquired the Arctic Zone® brand of coolers. Arctic Zone is a leading brand in the insulated products marketplace. In 2005, the company entered into a licensing agreement with Columbia Sportswear Company® to market coolers, lunch packs, baby bags and drin...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale ...

Medivation, Inc.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer, Inc to develop an...

Pfizer Consumer Healthcare

Centrum Silver

OncoImmune, Inc.

OncoImmune (www.oncoimmune.com) is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel immunotherapies for cancer, inflammation and autoimmune diseases. OncoImmune entered into a license and option agreement in 2016 with Pfizer Inc. regarding ONC-392, a pre-clinical IO program. OncoI...

Orion Research LLC

Orion Research LLC provides investigative research on public companies and was hired by Pershing Square Capital Management, L.P. to gather information on Herbalife and its Nutrition Clubs. Christine Richard, a former reporter with Bloomberg News, winner of seven national reporting awards for investigative articles, and the author of Confidence Game (Wiley ...

ARTEMISPharmaceuticals GmbH

ARTEMIS has developed the ArteMice™ platform, a combination of rapid and sophisticated gene vector design, efficient and expert ES cell transfection techniques, novel blastocyst injection techniques and the patented CreER gene switch. Together the ArteMice™ platform makes sophisticated, genetically modified mice for target validation, ADME/T and basic research available faster than ever before...

pSivida Corp.

pSivida Corp. is a world leader in the development of tiny, sustained release, drug delivery products and technologies that are administered by implantation, insertion or injection. The Company uses these systems to develop treatments for serious, unmet, medical needs. pSivida’s intellectual property portfolio consists of 59 patent families, more than...

Antisense Pharma GmbH

ANTISENSE PHARMA is an innovative biotech company aimed at developing and marketing novel antisense technology based drugs for the treatment of cancer and other so far incurable diseases.Founded in Göttingen 1998, the company is now headquartered in the BioPark in Regensburg, one of the most prominent Biotech centers in Germany. ANTISENSE PHARMA is run by corporate executives with a strong track ...

Gene Signal

Gene Signal (www.genesignal.com) is developing a robust pipeline of novel antisense oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions based on its innovative angiogenesis modulating technology. The company’s most advanced therapeutic product is aganirsen (GS-101), an antisense oligonucleotide that has nearly completed...

Nature Technology Corporation

Nature Technology Corporation is a technology-based service company, providing vector development and manufacturing assistance to biotech companies and academic researchers worldwide. NTC’s mission is to provide essential platform technology and services for the construction, delivery, and expression of genes. Nature Technology Corporation is dedicated to innovating, developing and providing cos...

Pfizer Inc. & Bristol-Myers Squibb

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise i...

Bristol-Myers Squibb and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise i...

Bristol-Myers Squibb Company and Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize Eliquis, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in...

Bristol-Myers Squibb-Pfizer Alliance

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise i...

Medical Discoveries Inc.

Medical Discoveries, Inc. develops cures for major diseases though its novel oxidative therapy program, in-licensing promising technologies, and establishing development/marketing alliances for programs that address some of today’s most serious illnesses. The Company was founded on MDI-P, a novel oxidative therapy which is a stable solution rich in highly reactive hydrogen, chlorine and oxygen...

International Food and Agricultural Trade Policy Council

The WTO’s Doha Round negotiations are at a crucial stage. Though there has been some progress towards convergence of different views, many of the key elements of an agricultural agreement are still to be decided. The deadline of April 30 established by Ministers in Hong Kong for the agreement on modalities has been missed, and such an agreement may not come for several weeks. Without the agricul...

Carl Stuart Limited

We have been serving the Scientific Community and Science based Industries since 1984. Through our commitment to service and quality, our business has grown substantially over the years. Carl Stuart Ltd's products and value added services are routinely used in a large cross section of industries, Institutions & Goverment bodies.Carl Stuart Limited are pleased to announce the agreement with BioPure...


More From BioPortfolio on "Akcea Pfizer Announce Licensing Agreement Investigative Antisense Therapy"

Quick Search

Corporate Database Quicklinks